Concepedia

Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses

Richard Harrop, Noel Drury, William Shingler, P. Chikoti, Irina Redchenko, Miles W. Carroll, Susan M. Kingsman, Stuart Naylor, Richard W. Griffiths, Neil Steven,

Cancer Immunology Immunotherapy · 2007 · 85 citations · 20 references

DOIFull text

Open access

Concepts

References

20

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

Christophe Tournigand, Thierry André, Emmanuel Achille et al. · Journal of Clinical Oncology · 2003 · 2.9K citations · Full text

, , +13

Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

M. E. Christine Lutsiak, Roshanak Tolouei Semnani, Roberto De Pascalis et al. · Blood · 2005 · 896 citations · Full text

, , +16

CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

François Ghiringhelli, Nicolas Larmonier, E. Schmitt et al. · European Journal of Immunology · 2004 · 868 citations

, , +17

Nonreplicating vaccinia vector efficiently expresses recombinant genes.

Gerd Sutter, Bernard Moss · Proceedings of the National Academy of Sciences · 1992 · 605 citations

, , +17

Phase I Study in Advanced Cancer Patients of a Diversified Prime-and-Boost Vaccination Protocol Using Recombinant Vaccinia Virus and Recombinant Nonreplicating Avipox Virus to Elicit Anti–Carcinoembryonic Antigen Immune Responses

John L. Marshall, Robert J. Hoyer, Mary Ann Toomey et al. · Journal of Clinical Oncology · 2000 · 357 citations

, , +17